BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greenhill LL, Swanson JM, Hechtman L, Waxmonsky J, Arnold LE, Molina BSG, Hinshaw SP, Jensen PS, Abikoff HB, Wigal T, Stehli A, Howard A, Hermanussen M, Hanć T; MTA Cooperative Group. Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry 2020;59:978-89. [PMID: 31421233 DOI: 10.1016/j.jaac.2019.06.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Lohr WD, Wanta JW, Baker M, Grudnikoff E, Morgan W, Chhabra D, Lee T. Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis. Front Psychiatry 2021;12:642798. [PMID: 33959050 DOI: 10.3389/fpsyt.2021.642798] [Reference Citation Analysis]
2 Charach A. Editorial: Time for a New Conversation on Stimulant Use. J Am Acad Child Adolesc Psychiatry 2020;59:929-30. [PMID: 31634569 DOI: 10.1016/j.jaac.2019.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Johnstone JM, Hatsu I, Tost G, Srikanth P, Eiterman LP, Bruton AM, Ast HK, Robinette LM, Stern MM, Millington EG, Gracious BL, Hughes AJ, Leung BMY, Arnold LE. Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial. J Am Acad Child Adolesc Psychiatry 2021:S0890-8567(21)00473-1. [PMID: 34303786 DOI: 10.1016/j.jaac.2021.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Arnold LE, Johnstone J, Gracious B, Hughes AJ, Hatsu I, Leung B, Sibley MH. Elements of the New Conversation. J Am Acad Child Adolesc Psychiatry 2020;59:1310-1. [PMID: 32949712 DOI: 10.1016/j.jaac.2020.08.438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Farhat LC, Flores JM, Behling E, Avila-Quintero VJ, Lombroso A, Cortese S, Polanczyk GV, Bloch MH. The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis. Mol Psychiatry 2022. [PMID: 35027679 DOI: 10.1038/s41380-021-01391-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Khan RB, Bano M, Wang F, Haitao P, Christensen A, Smith J, Simmons A, Sadighi ZS. Height, weight, and cardiovascular effects of stimulants on children with brain tumors. Pediatr Blood Cancer 2021;68:e28740. [PMID: 33049111 DOI: 10.1002/pbc.28740] [Reference Citation Analysis]
7 Childress AC, Beltran N, Supnet C, Weiss MD. Reviewing the role of emerging therapies in the ADHD armamentarium. Expert Opin Emerg Drugs 2021;26:1-16. [PMID: 33143485 DOI: 10.1080/14728214.2020.1846718] [Reference Citation Analysis]
8 Young JR, Yanagihara A, Dew R, Kollins SH. Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions. CNS Drugs 2021;35:403-24. [PMID: 33770390 DOI: 10.1007/s40263-021-00806-z] [Reference Citation Analysis]
9 Fast K, Björk A, Strandberg M, Johannesson E, Wentz E, Dahlgren J. Half of the children with overweight or obesity and attention-deficit/hyperactivity disorder reach normal weight with stimulants. Acta Paediatr 2021;110:2825-32. [PMID: 33876865 DOI: 10.1111/apa.15881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Corona JC. Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder. Antioxidants (Basel) 2020;9:E1039. [PMID: 33114154 DOI: 10.3390/antiox9111039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang LJ, Huang YH, Chou WJ, Lee SY. Growth Hormone and Thyroid Function in Children With Attention Deficit Hyperactivity Disorder Undergoing Drug Therapy. J Clin Endocrinol Metab 2022;107:2047-56. [PMID: 35262170 DOI: 10.1210/clinem/dgac139] [Reference Citation Analysis]
12 Çevikaslan A, Parlak M, Ellidağ HY, Kulaksızoğlu SÇ, Yılmaz N. Effects of methylphenidate on height, weight and blood biochemistry parameters in prepubertal boys with attention deficit hyperactivity disorder: an open label prospective study. Scand J Child Adolesc Psychiatr Psychol 2021;9:163-73. [PMID: 34549033 DOI: 10.21307/sjcapp-2021-018] [Reference Citation Analysis]
13 Vitulano LA, Mitchell JT, Vitulano ML, Leckman JF, Saunders D, Davis N, Woodward D, Goodhue B, Artukoglu B, Kober H. Parental perspectives on attention-deficit/hyperactivity disorder treatments for children. Clin Child Psychol Psychiatry 2022;:13591045221108836. [PMID: 35695509 DOI: 10.1177/13591045221108836] [Reference Citation Analysis]
14 Baweja R, Hale DE, Waxmonsky JG. Impact of CNS Stimulants for Attention-Deficit/Hyperactivity Disorder on Growth: Epidemiology and Approaches to Management in Children and Adolescents. CNS Drugs 2021;35:839-59. [PMID: 34297331 DOI: 10.1007/s40263-021-00841-w] [Reference Citation Analysis]
15 Mechler K, Banaschewski T, Hohmann S, Häge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol Ther 2021;:107940. [PMID: 34174276 DOI: 10.1016/j.pharmthera.2021.107940] [Reference Citation Analysis]
16 Greydanus DE, Rowland DC, Patel DR, Soares N. Psychopharmacology of Pediatric Attention-Deficit/Hyperactivity Disorder. Psychiatric Annals 2021;51:459-66. [DOI: 10.3928/00485713-20210914-01] [Reference Citation Analysis]
17 Lawrence K, Myrissa K, Toribio-Mateas M, Minini L, Gregory AM. Trialling a microbiome-targeted dietary intervention in children with ADHD-the rationale and a non-randomised feasibility study. Pilot Feasibility Stud 2022;8:108. [PMID: 35606889 DOI: 10.1186/s40814-022-01058-4] [Reference Citation Analysis]
18 Waxmonsky JG, Pelham WE 3rd, Baweja R, Hale D, Pelham WE Jr. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder. J Pediatr 2021:S0022-3476(21)00906-9. [PMID: 34571023 DOI: 10.1016/j.jpeds.2021.09.030] [Reference Citation Analysis]
19 Posner J, Polanczyk GV, Sonuga-Barke E. Attention-deficit hyperactivity disorder. Lancet 2020;395:450-62. [PMID: 31982036 DOI: 10.1016/S0140-6736(19)33004-1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 33] [Article Influence: 38.5] [Reference Citation Analysis]
20 Racicka-Pawlukiewicz E, Hanć T, Kuć K, Bielecki M, Zaorska J, Wolańczyk T, Bryńska A. The Occurrence of Overweight and Obesity in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder According to Three Different Diagnostic Criteria for Obesity. J Child Adolesc Psychopharmacol 2021;31:430-8. [PMID: 33411571 DOI: 10.1089/cap.2020.0075] [Reference Citation Analysis]
21 Guo Y, Wang J, Yan S, Sui S, Garg D. Clinical Efficacy Evaluation of Psychological Nursing Intervention Combined with Drugs Treatment of Children with ADHD under Artificial Intelligence. Journal of Healthcare Engineering 2022;2022:1-10. [DOI: 10.1155/2022/1818693] [Reference Citation Analysis]
22 Yackobovitch-Gavan M, Mimouni-Bloch A, Gabbay U, Carmi D, Goldstein B, Keinan-Boker L, Bloch S, Meyerovitch J. Sex-Specific Long-Term Height and Body Mass Index Trajectories of Children Diagnosed with Attention-Deficit/Hyperactivity Disorder and Treated with Stimulants. J Pediatr 2021:S0022-3476(21)00685-5. [PMID: 34293373 DOI: 10.1016/j.jpeds.2021.07.018] [Reference Citation Analysis]